Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia

摘要

Disclosed is a method of medical management for men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH), involving combination therapy of an alpha1-adrenergic antagonist, i.e., terazosin in combination with a phytotherapeutic agent, Serenoa repens (saw palmetto) extract. The combination provides relief from both dynamic and mechanical obstructive effects of benign prostatic hyperplasia. Therapeutic compositions useful for such treatment and pharmaceutical-nutraceutical kits containing such compositions are disclosed.